HBIO Quote, Trading Chart, Harvard Bioscience Inc.
home / stock / hbio / hbio quote
$7.34 Last:
-4.92% Change Percent:
$7.71 Open:
$7.34 Previous Close:
$7.72 High:
$7.31 Low:
151,970 Volume:
06/17/2021 04:42:51 am Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
HBIO Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2021-06-17 | 7.71 | 7.34 | 7.72 | 7.31 | 151,970 |
| 2021-06-16 | 7.45 | 7.72 | 7.83 | 7.41 | 222,080 |
| 2021-06-15 | 7.3 | 7.55 | 7.61 | 7.15 | 335,869 |
| 2021-06-14 | 7.64 | 7.35 | 7.75 | 7.3 | 172,574 |
| 2021-06-11 | 7.71 | 7.64 | 7.83 | 7.62 | 160,703 |
| 2021-06-10 | 7.64 | 7.72 | 7.85 | 7.5 | 478,820 |
| 2021-06-09 | 7.38 | 7.64 | 7.74 | 7.38 | 321,113 |
| 2021-06-08 | 7.27 | 7.48 | 7.49 | 7.27 | 175,957 |
| 2021-06-07 | 7.09 | 7.28 | 7.44 | 7.09 | 269,916 |
| 2021-06-04 | 7.13 | 7.13 | 7.2499 | 7.06 | 149,918 |
| 2021-06-03 | 7.03 | 7.13 | 7.205 | 6.98 | 176,567 |
| 2021-06-02 | 7.26 | 7.15 | 7.4 | 7.11 | 218,978 |
| 2021-06-01 | 7.06 | 7.3 | 7.42 | 7 | 309,602 |
| 2021-05-31 | 6.84 | 7 | 7.12 | 6.84 | 215,226 |
| 2021-05-28 | 6.84 | 7 | 7.12 | 6.84 | 215,225 |
| 2021-05-27 | 7 | 6.84 | 7.04 | 6.79 | 372,526 |
| 2021-05-26 | 6.96 | 6.97 | 7.02 | 6.8 | 262,604 |
| 2021-05-25 | 7.415 | 6.94 | 7.415 | 6.88 | 233,265 |
| 2021-05-24 | 7.14 | 7.27 | 7.36 | 7.11 | 195,075 |
| 2021-05-21 | 7.06 | 7.15 | 7.305 | 7.03 | 297,804 |
Harvard Bioscience Inc. Company Name:
HBIO Stock Symbol:
NASDAQ Market:
Harvard Bioscience Inc. Website:
News, Short Squeeze, Breakout and More Instantly...
-
Sales effectiveness, pre-clinical product demand and disciplined cost management result in improved revenues and margins Revenue up 14% as sales momentum from Q4’20 continues Pre-clinical product revenue up 24% Operating margin significantly improves year-over-year on...
-
HOLLISTON, Mass., April 19, 2021 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for first quarter ended March 31, 2021 before the market opens on May 6, 2021, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time. ...
-
Revenue returns to pre-Covid19 levels on strong CRO/pharma sales Operating margin increased year-over-year on GAAP and an adjusted basis New debt facility significantly reduces annual interest expense HOLLISTON, Mass., March 10, 2021 (GLOBE NEWSWIRE) -- Harvard Bioscience,...